T3 · Product exporter position

United Kingdom exports of Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments (HS 300670)

See where United Kingdom stands in pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments: export scale, destination breadth, market position, growth, and reported trade history.

Exporter GBRHS6 300670Latest year 2024Declining

Latest exports

$10.4MLatest observed lane total

Destination markets

115Reported active markets

Three-year growth

-4.4%Annualized change

Destination HHI

951Destination concentration

Weighted share

11.3%Reported market position

Exporter evidence

How strong is United Kingdom in Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?

Reported exporter totals and calculated indicators for HS 300670. Values retain their observed coverage period.

Exporter scale

Latest exports$10.4M
Current 2024 exports$9.5M
Three-year average$10.0M
Historical peak$363.3M

Market position

Active destinations115
Destination HHI951
Weighted share11.3%
Share change+1.8 pp

Competitiveness

Three-year growth-4.4%
Volatility1.4
Maximum drawdown96.6%
TrendDeclining
MeasureValueWhat it describes
ExporterUnited KingdomCountry represented by this profile
Latest observed exports$10.4MSum of latest observed destination-lane values
Current 2024 exports$9.5MCommon-year comparison where reported
Three-year growth-4.4%Annualized change in exporter totals
Five-year growth-18.6%Annualized change in exporter totals
Leading destinationUSADestination with the largest observed export value
Leading destination share26.1%Share of observed exporter totals
Destination concentration951HHI across destination markets
Weighted share change+1.8 ppValue-weighted latest change in market share
Limited-history lanes13.5%Share of lanes with shorter history

Destination markets

Where does United Kingdom sell pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
USA, Puerto Rico and US Virgin Islands$2.7M3.8%+3.7%0% tariffSlowing
United Kingdom$534.3K2.6%+405.4%0% tariffStable
Germany$466.8K3.7%+23.4%FTA reportedDeclining
Australia$335.8K3%+4.3%0.1% tariffSlowing

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports
$2.7M
Market share
3.8%
Growth
+3.7%
Access
0% tariff
Signal
Slowing

Destination

United Kingdom

Latest exports
$534.3K
Market share
2.6%
Growth
+405.4%
Access
0% tariff
Signal
Stable

Destination

Germany

Latest exports
$466.8K
Market share
3.7%
Growth
+23.4%
Access
FTA reported
Signal
Declining

Destination

Australia

Latest exports
$335.8K
Market share
3%
Growth
+4.3%
Access
0.1% tariff
Signal
Slowing

Price intelligence

How does United Kingdom's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Ecuador: $38.8M / ton.

Lowest reported price

Sri Lanka: $52.9 / ton.

Median price

$20.4K / ton across reported markets.

Export trend

Reported export history

Annual observations for United Kingdom and HS 300670 where available.

YearExportsYear-on-year changeActive destinations
2010$24.7M+39.3%113
2011$18.0M-27.2%117
2012$17.7M-1.8%117
2013$16.9M-4.2%112
2014$15.6M-7.7%120
2015$18.7M+19.7%118
2016$21.1M+13%127
2017$23.0M+9%124
2018$28.3M+22.9%125
2019$26.5M-6.2%127
2020$18.7M-29.3%118
2021$10.9M-42%119
2022$8.9M-17.7%104
2023$11.7M+30.7%112
2024$9.5M-18.8%115

Exporter context

United Kingdom economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300670.

United Kingdom has reported exports of $442.2B and a trade balance of -$311.2B in 2024.

Available structural indicators include 35.3% trade openness, 17.9% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about United Kingdom pharmaceutical goods: gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.